Safety and Effectiveness of Endovascular Therapy After 8 Hours of Acute Ischemic Stroke Onset and Wake-Up Strokes
Authors:
- 1 October 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 40 (10) , 3269-3274
Abstract
Background and Purpose— This is a retrospective review of patients who underwent endovascular recanalization ≥8 hours after acute ischemic stroke symptom onset, including wake-up strokes, between June 2005 and June 2008. Methods— Thirty patients with a premorbid modified Rankin score ≤1 and NIHSS between 5 and 22 were included. All had admission CT, CTA, and CT perfusion scans to evaluate for salvageable brain tissue. Recanalization effectiveness was assessed by angiograms obtained within 30 hours after intervention. Patient, treatment characteristics, and immediate and 3-month outcomes were analyzed. Results— Mean NIHSS at presentation was 13 (median=12). Mean interval between time last-seen well and angiogram was 12.75 hours (median=10). Twenty-six patients (86.7%) presented with complete-to-near-complete vessel occlusion (thrombolysis in myocardial infarction [TIMI] 0/1); 4 had partial vessel occlusion (TIMI 2). Interventions included intra-arterial pharmacological thrombolysis (n=10), mechanical thrombectomy(n=21; Merci, 16; intracranial stent, 9; extracranial stent, 3), angioplasty (n=14; intracranial, 11; extracranial, 3). Nine patients received GPIIb/IIIa inhibitors (eptifibatide); all received heparin. Partial-to-complete recanalization (TIMI 2/3) was achieved in 20 patients (66.7%). Procedure-related complications included vascular perforations (n=3) and femoral access site complication (n=1). One patient had an embolic anterior cerebral artery infarct during intervention; another had progression of brain stem infarct. Symptomatic intracerebral hemorrhage occurred in 3 patients (10%), with 2 being primarily subarachnoid in location. Total in-hospital mortality including procedural mortality, disease progression, or other comorbidities was 23.3% (n=7). Mean discharge NIHSS was 9.5, representing an overall NIHSS 3.5-point improvement. Overall, mean modified Rankin score at death or last follow-up (mean=10.6 months) was 4.2. At 3 months, total mortality was 33.3% (n=10), 20% had modified Rankin score ≤2, and 33% had modified Rankin score ≤3. Among survivors, mean modified Rankin score at 3-month follow-up was 3. Conclusion— Our data show that delayed endovascular revascularization of carefully selected patients is safe, effective, and improves clinical outcome.Keywords
This publication has 33 references indexed in Scilit:
- Endovascular Therapy for Acute Ischemic StrokeStroke, 2009
- Thrombolytic Therapy for Patients Who Wake-Up With StrokeStroke, 2009
- Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled studyThe Lancet Neurology, 2009
- Quantitative Assessment of Core/Penumbra Mismatch in Acute StrokeStroke, 2008
- Mechanical Thrombectomy for Acute Ischemic StrokeStroke, 2008
- The Impact of Recanalization on Ischemic Stroke OutcomeStroke, 2007
- Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS)Stroke, 2006
- Perfusion-CT Assessment of Infarct Core and PenumbraStroke, 2006
- Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke PatientsStroke, 2006
- Thrombolytic Therapy With Recombinant Tissue Plasminogen Activator for Acute Ischemic StrokeStroke, 2003